SEC Form 4 · accession 0001681171-16-000002
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah B Kavanagh
Director
Period of report
Jul 27, 2016
Accepted (ET)
Aug 8, 2016 · 8:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, no par valueF1,F2 | Jul 27, 2016 | A | 14,458 | $0.00 | A | 14,458 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents Restricted Share Units ("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- F2Prorated annual grant of restricted stock units equal to $339,640. Pricing is based on the closing price of registrant common stock on the date of grant.